Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Video

» Interview

Beyond the Data: Delving Deeper Into REVIVED-BCIS2

October 6, 2022

Video

» Live Case

Case Based 3 Transcatheter Mitral Valve In MAC and Bioprosthetic Valve Failure

September 19, 2022

Video

» Interview

Beyond the Data: Revascularization and Heart Failure

September 17, 2022

Video

» Interview

Beyond the Data: New in HF From ESC 2022

September 6, 2022

Video

» Interview

Beyond the Data: DELIVERING the Details on Dapagliflozin

August 28, 2022

Video

» Live Case

Case-based Heart Failure- TAVR in Patients w Heart Failure and HFrEF

June 17, 2022

Video

» Interview

Beyond the Data: DEFINE-HF and PRESERVED-HF

May 26, 2022

Video

» Interview

Beyond the Data: GALACTIC-HF

May 23, 2022

Video

» Interview

SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure

May 4, 2022

Video

» Interview

METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction

May 4, 2022

Video

» On Record

Heart Failure Highlights from ACC 2022

April 13, 2022

Video

» Interview

Beyond the Data: Heart Failure Updates and Key Takeaways

April 3, 2022

Video

» Interview

ACC 2022: DIAMOND Trial: Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications for Heart Failure with Reduced Ejection Fraction

April 3, 2022

Advertisement

Beyond the Data: Delving Deeper Into REVIVED-BCIS2

Case Based 3 Transcatheter Mitral Valve In MAC and Bioprosthetic Valve Failure

Beyond the Data: Revascularization and Heart Failure

Beyond the Data: New in HF From ESC 2022

Beyond the Data: DELIVERING the Details on Dapagliflozin

Case-based Heart Failure- TAVR in Patients w Heart Failure and HFrEF

Beyond the Data: DEFINE-HF and PRESERVED-HF

Beyond the Data: GALACTIC-HF

SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure

METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction

Heart Failure Highlights from ACC 2022

Beyond the Data: Heart Failure Updates and Key Takeaways

ACC 2022: DIAMOND Trial: Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications for Heart Failure with Reduced Ejection Fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content